Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132819) titled 'A Randomized Controlled Study Comparing the Efficacy and Safety of R2-CHOP versus R-CHOP as First-Line Treatment for Elderly Patients with HIV-Associated Diffuse Large B-Cell Lymphoma' on Sept. 18.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Southern Medical University Southern Hospital
Condition:
Diffuse large B-cell lymphoma (DLBCL)
HIV infection (HIV-positive status)
Intervention:
Trial group (R2-CHOP):Treatment with lenalidomide + rituximab + cyclophosphamide + doxorubicin + vincristine + prednisone regimen
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enr...